Under 250 mg a day
US adults average well under the 250 mg a day of EPA and DHA that health authorities suggest for heart health.
Peer-reviewed analysisWild Fish Oil Concentrate is the lead active here, studied most for blood flow. 15 human studies on Wild Fish Oil Concentrate back this formula, each one cited. Who it fits: for everyone, adults.
Verified by IngredientMDThe panel on the left is the one we evaluated, line by line.
All 8 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Backed by human trials".
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Cross-checked against 631 documented interactions for these actives.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
Under 250 mg a day
US adults average well under the 250 mg a day of EPA and DHA that health authorities suggest for heart health.
Peer-reviewed analysis89% of US adults
aged 19 and over consumed more than the recommended 2,300 milligrams of sodium a day, in a CDC analysis of 2009 to 2012 dietary survey data.
CDC Morbidity and Mortality Weekly Report, 201457.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health Statistics65.5% of US adults aged 20 to 64
had a blood cholesterol check by a health professional in the past 12 months in 2017, up from 58.0% in 2012, in the National Health Interview Survey.
CDC National Center for Health Statistics, 2019Fewer than 1 in 5 US adults
know their cholesterol or blood sugar numbers, according to a national survey fielded for The Ohio State University Wexner Medical Center in December 2023.
SSRS Opinion Panel Omnibus for The Ohio State University Wexner Medical Center, 20239% of US women
and 5% of US men are getting the recommended daily amount of dietary fibre, based on National Health and Nutrition Examination Survey data collected from 2013 to 2018.
American Society for Nutrition, 202159 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Meta-analysis, 2022
Across 71 trials, taking 2 to 3 grams a day of DHA and EPA together lowered the top blood pressure number by about 2.6 points.
Journal of the American Heart AssociationMeta-analysis, 2017
Across 51 trials in about 3,000 people, marine omega-3s lowered resting heart rate by about 2.2 beats per minute, an effect linked to DHA rather than EPA.
European Journal of Clinical NutritionMeta-analysis, 2023
Across 90 trials in 72,598 people, higher daily DHA and EPA intake lowered blood triglycerides and non-HDL cholesterol in a near-linear way, most clear above about 2 g a day.
Journal of the American Heart AssociationSystematic review, 2025
Reviewing human studies, regular extra virgin olive oil intake was associated with better blood vessel function and improved blood lipid measures.
NutrientsMeta-analysis, 2024
Pooled trials found sesame supplements changed cholesterol levels, though effects on body composition were less consistent.
Nutrition, Metabolism and Cardiovascular DiseasesMeta-analysis, 2026
A pooled analysis of trials of polyphenol intake reported neurological and cognitive measures, with certainty ratings given for each estimate.
Food and FunctionRandomised trial, 2026
In adults with mildly to moderately raised blood pressure, olive leaf extract given together with potassium lowered blood pressure relative to control, so the effect belongs to the combination.
PhytomedicineRandomised trial, 2026
Phenolic-rich extra virgin olive oil taken with prebiotics improved measures of muscle mass and physical function in the older adults studied.
Journal of cachexia, sarcopenia and muscleRandomised trial, 2026
A (poly)phenol-rich cranberry drink was compared with placebo for its effect on self-reported mood and stress measures in university students.
Randomised trialMeta-analysis, 2026
Across the pooled trials, blackcurrant anthocyanin supplementation shifted the mix of fuels used during exercise.
Journal of dietary supplementsRandomised trial, 2025
In adults with higher liver fat, hydroxytyrosol improved liver fat and metabolic readings, and the change tracked alongside shifts in the gut microbiota.
Journal of Agricultural and Food ChemistryMeta-analysis, 2026
A certainty-rated pooling of curcumin trials reports pooled results alongside how confident the authors are in each one.
Phytotherapy ResearchMeta-analysis, 2026
Pooling nine placebo-controlled eccentric-exercise trials in healthy adults, long-chain omega-3 fats reduced delayed onset muscle soreness (Hedges g -0.75) and the muscle-damage marker creatine kinase (-0.40) and improved muscle strength (0.45) and range of motion (0.93) at the point of worst impairment.
NutrientsMeta-analysis, 2021
Across 33 trials, DHA lowered blood triglycerides and raised HDL cholesterol by about 0.07 mmol/L, but also raised LDL cholesterol by about 0.26 mmol/L.
Clinical NutritionMeta-analysis, 2020
Across trials in older adults with mild memory complaints, DHA was linked to better memory test scores, though no difference was detected in those without complaints, which does not mean none exists.
European journal of clinical pharmacologyMeta-analysis, 2026
Pooled trials looked at omega-3s against inflammation markers and recovery measures in sport, with omega-6 relevance only indirect through shared pathways.
FASEB journalCohort study, 2024
Reported that the association between dietary vegetable oil intake and cardiometabolic risk factors differed by FADS1 rs174556 genotype.
Scientific ReportsMeta-analysis, 2025
Pooling randomised trials, olive polyphenols including hydroxytyrosol improved several cardiometabolic risk markers in adults, with effects modest in size.
Critical Reviews in Food Science and NutritionMeta-analysis, 2026
Pooling human trials, oleuropein and olive leaf extract were associated with improvements in metabolic and inflammatory blood markers.
Food & FunctionRandomised trial, 2026
In postmenopausal women, a polyphenol supplement raised some blood fat levels while improving LDL particle quality and lowering LDL oxidation, all blood markers, not clinical outcomes.
European journal of nutritionOpen-label trial, 2026
Olive extract supplementation was evaluated against blood pressure and cardiovascular health markers in adults. The indexed record does not state the allocation method, and oleuropein is named as a constituent of the extract rather than tested alone.
PLOS OneMeta-analysis, 2026
Pooling high-dose EPA trials, the authors report that observed cardiovascular outcomes differed by the formulation studied rather than being uniform across preparations.
American Journal of Cardiovascular DrugsMeta-analysis, 2025
Across seven trials in 439 adults with elevated liver fat, fish oil moved triglycerides (standardised mean difference -0.40), the liver enzyme AST (-0.29), insulin resistance measured by HOMA-IR and waist circumference (-0.31) in a favourable direction, while ALT, GGT, body mass index and LDL cholesterol showed no detectable change.
Frontiers in NutritionRandomised trial, 2022
The authors report improvements in inflammatory and glycaemic laboratory markers with extra virgin olive oil supplementation alongside a structured diet. These are markers, not clinical events.
Frontiers in EndocrinologyRandomised trial, 2025
Oleuropein supplementation raised resting skeletal muscle pyruvate dehydrogenase activity, a metabolic marker, and the trial did not detect a change in the other outcomes measured.
The Journal of NutritionRandomised trial, 2025
Hydroxytyrosol supplementation improved antioxidant and inflammatory marker readings in adults carrying excess body weight compared with placebo. Markers, not outcomes.
Clinical NutritionControlled clinical trial, 2016
Hydroxytyrosol supplementation altered the expression of specific microRNAs in humans, a mechanistic signal rather than a measured health outcome.
The Journal of Nutritional BiochemistryMeta-analysis, 2022
Across trials, EPA lowered LDL cholesterol about 8.5 mg/L more than DHA, while the two acted much alike on the other markers measured.
Nutrition, Metabolism and Cardiovascular DiseasesMeta-analysis, 2026
Pooled trials found that the EPA to DHA ratio of a supplement shapes which fatty acids rise in the blood, with higher EPA shares linked to larger falls in circulating inflammatory markers, which are blood measures rather than outcomes.
Critical reviews in food science and nutritionSystematic review, 2025
The review found that supplementation raised blood DHA status in people following a long-term protein-restricted diet, with the authors describing the functional outcome evidence as limited.
Frontiers in NutritionMeta-analysis, 2021
In head to head and network comparisons of 20 randomised trials, EPA and DHA moved C-reactive protein, interleukin-6 and TNF-alpha to a similar degree, with no difference detected between the two.
Advances in NutritionMeta-analysis, 2026
Pooled human trials examined how polyphenol supplementation changes gut bacterial composition and the short-chain fatty acids measured in stool.
NutrientsRandomised trial, 2026
A trial combining a Mediterranean-style diet with extra virgin olive oil found shifts in gut bacteria makeup, a compositional marker.
LifeSystematic review, 2025
Across the human consumption studies reviewed, extra virgin olive oil intake was linked to lower liver fat and improved liver enzyme measures in adults with elevated liver fat.
NutrientsMeta-analysis, 2026
A pooled analysis of trials of combined EPA and DHA supplementation reporting change in itch severity scores, a patient-reported measure.
PharmaceuticalsMeta-analysis, 2026
Pooling trials of DHA taken during pregnancy, the review found only small and inconsistent differences in later child neurodevelopmental scores.
Developmental psychobiologyMeta-analysis, 2024
Pooling 15 trials in pregnant women, fish oil capsules showed no detectable difference from placebo in blood sugar or blood lipid measures overall, with a lower HOMA-IR (mean difference -0.60) in the subgroup taking under 200 mg of EPA.
Nutrition ReviewsRandomised trial, 2025
Taking DHA through pregnancy and early lactation raised the DHA content of breast milk compared with control.
Randomised trialMeta-analysis, 2024
Across nine randomised trials, 450 to 800 mg a day of DHA in the second half of pregnancy was linked to infant birth weight about 102 g higher, with no difference detected in gestation length.
Nutrition ResearchPopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
In the trial record, EPA in blood plasma plateaus after 4 to 8 weeks of daily fish oil, while EPA in the red blood cell membrane rises with a 28 day half-life and reaches a steady state at about 180 days.
In a randomised single-blind trial, 20 participants took either fish oil supplying 1,296 mg EPA and 864 mg DHA daily or flaxseed oil for eight weeks, with erythrocyte membrane and plasma samples drawn at weeks 0, 4, 8, 10, 12, 14, 16 and 24. On fish oil, erythrocyte membrane EPA rose 300 percent and DHA rose 42 percent by week eight. Levels held until about week 12 and then declined across the post-supplementation sampling, faster in plasma phospholipids than in erythrocyte membranes. Membrane fatty acid content was measured, not a symptom, and this is one trial of 20 people.
In a randomised double-blind crossover trial, healthy men and women aged 19 to 34 took capsules supplying about 4 g DHA per day, with plasma sampled at days 0, 1, 3, 7, 14 and 28. DHA concentrations tripled and so did DHA-derived oxylipins. Increases were detectable as early as day 1, and 11 of 12 individual DHA oxylipins plus total DHA oxylipins reached a plateau by days 5 to 7. The plateau came earlier and was reached by more oxylipins in females than in males. Plasma marker chemistry was measured, not a feeling.
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
8 ingredients, from each one's own page.
Membrane incorporation takes weeks. An omega-3 index blood test starts moving by about four weeks and settles across three to four months of daily use.
EPA has to work its way into cell membranes, and an omega 3 index blood test picks up most of the change by weeks eight to twelve of daily use.
Red blood cell omega-3 levels climb over roughly eight to twelve weeks of steady daily intake. That is where the change shows up, on a fatty acid panel rather than as a sensation.
In a capsule it works from the first dose, carrying fat-soluble nutrients into micelles. Blood panel changes take three to six weeks of food-level daily intake.
Blood-flow measures shift within hours of a single serving in laboratory settings. The changes you might notice in digestion and skin build across four to twelve weeks.
It runs on a marker timeline rather than a felt one. Trials pick up changes in oxidation markers after roughly three weeks of daily use.
Blood pressure and oxidative stress markers in trials shift across four to eight weeks of daily use. That's a change you read on a panel rather than notice hour to hour.
Marker changes in trials are read over weeks, typically four to eight. As a cooking oil it does its work quietly from the first meal.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
It is a softgel, so the active is already dissolved in oil and the shell keeps it away from air and light.
Because the effect builds and holds only with continued daily use, a steady recurring supply is the practical way to keep it going.
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.